Apomorphineinjection Apomorphine, a potent non-selective dopamine agonist, is primarily recognized for its therapeutic applications in managing Parkinson's disease (PD) and, to a lesser extent, erectile dysfunction. While not a peptide itself, its mechanism of action and historical development are deeply intertwined with understanding neurotransmitter systems. This article delves into the multifaceted nature of apomorphine, exploring its pharmacological properties, clinical uses, administration methods, and potential side effectsApomorphine HCl - Focus Biomolecules.
Apomorphine functions by mimicking the effects of dopamine, a crucial neurotransmitter involved in regulating movement, mood, and reward pathways in the brain. In conditions like Parkinson's disease, there is a significant depletion of dopamine-producing neurons, leading to motor symptoms such as rigidity, tremors, and slowness of movement.作者：A Miyauchi·2024·被引用次数：12—Apomorphineis a known treatment for Parkinson's disease (PD) and erectile dysfunction. It is a broad-spectrum dopamine agonist for all subtypes ... Apomorphine acts as a dopamine receptor agonist, binding to and activating dopamine receptors (specifically D1 and D2 subtypes) throughout the brain. This activation helps to compensate for the lack of natural dopamine, thereby alleviating motor fluctuations and improving mobility in patients with advanced PD. Its classification as an archetypal dopamine pan-receptor agonist highlights its broad activity across various dopamine receptor subtypes(−)-Apomorphine is a non-selective dopamine receptoragonist that exhibits pKi values of 6.43, 7.08, 7.59, 8.36, and 7.83 for human recombinant D1, D2L, D3, D4, and D5 receptors, respectively. It produces biphasic effects on locomotor activity and displays anti-Parkinsonian and neuroprotective actions..
The primary indication for apomorphine is the management of "off" episodes in advanced Parkinson's disease.R-(−)-Apomorphineacts as a non-selective D1 and D2 dopamine receptor agonist. It shows therapeutic effects against Parkinson′s disease and male erectile dysfunction. R-(−)-Apomorphinealso shows neuroprotective, radical scavenging, and emetic effects.Apomorphinestimulates the brain chemoreceptor trigger zone. These episodes are characterized by a return of motor symptoms or a significant decrease in motor function, often occurring as the patient's regular levodopa medication wears offR-(−)-Apomorphineacts as a non-selective D1 and D2 dopamine receptor agonist. It shows therapeutic effects against Parkinson′s disease and male erectile dysfunction. R-(−)-Apomorphinealso shows neuroprotective, radical scavenging, and emetic effects.Apomorphinestimulates the brain chemoreceptor trigger zone.. Apomorphine offers rapid relief from these debilitating "off" periods, providing a crucial therapeutic option when other treatments are insufficient.Apomorphine | 58-00-4 | FA44559 It is increasingly used worldwide as an add-on therapy, administered either intermittently or via continuous infusion for more consistent symptom controlApomorphine | C17H17NO2 | CID 6005 - PubChem - NIH.
Beyond Parkinson's disease, apomorphine has also shown efficacy in treating erectile dysfunction. By acting on dopamine receptors in the brain, it can help promote erections by influencing pathways related to sexual arousal.
Apomorphine is available in various formulations to suit different clinical needs and patient preferences(R)-(-)-Apomorphine hydrochloride - Tocris Bioscience. These include:
* Subcutaneous Injection: This is a common method for acute treatment of "off" episodes, offering rapid onset of action.
* Continuous Subcutaneous Infusion: For patients requiring more consistent symptom management, a continuous infusion pump delivers apomorphine steadily over time.
* Sublingual Film: A sublingual formulation provides an alternative route of administration for short-term relief of "off" episodes.
* Intramuscular Injection: While less common, intramuscular administration is also a possibilityApomorphine | C17H17NO2 | CID 6005 - PubChem - NIH.
Dosage is highly individualized and depends on the patient's condition, response, and tolerance.2025年9月15日—Apomorphine injectionis used to treat ''off'' episodes(times of difficulty moving, walking, and speaking that may happen as medication wears off or at random) Initial doses are typically low and gradually titrated upwards. For instance, an initial maintenance dose for treating recurring "off" episodes might be 3 mg used on an as-needed basis.
As with any potent medication, apomorphine can cause side effects.APOMORPHINE - Pharmaceutical Benefits Scheme ... Common adverse reactions include nausea, vomiting, dizziness, drowsiness, and injection site reactions (pain, redness, swelling). More serious side effects can include orthostatic hypotension (a drop in blood pressure upon standing), hallucinations, and dyskinesias (involuntary movements).
Apomorphine is contraindicated in individuals with hypersensitivity to the drug and in those with certain medical conditions.(R)-(-)-Apomorphine hydrochloride | Non-selective Dopamine Healthcare providers carefully assess patient history and current medications to determine suitability and manage potential risks.
While apomorphine itself is not a peptide, its study has contributed to a broader understanding of neurotransmitter systems, including opioid peptide precursor gene expression, as indicated by some research. Its role as a tool in scientific research extends to studying the effects of dopamine on physiological processes and investigating neuroprotective mechanisms, such as its potential to protect against MPTP-induced neurotoxicity in animal models. Ongoing research continues to explore novel applications and optimize its therapeutic use.
Join the newsletter to receive news, updates, new products and freebies in your inbox.